Patterns of restenosis in drug-eluting stents: Paclitaxel-eluting stents, female gender and overlapping stents are associated with non-focal restenosis

被引:0
|
作者
Corbett, Simon J.
Cosgrave, John
Babic, Rade
Melzi, Gloria
Biondi-Zoccai, Giuseppe G. L.
Godino, Cosmo
Morici, Nuccia
Flavio, Airoldi
Michev, Iassen
Chieffo, Alaide
Carlino, Mauro
Montorfano, Matteo
Sangiorgi, Giuseppe M.
Colombo, Antonio
机构
[1] EMO Ctr Cuore Columbus, Milan, Italy
[2] San Raffaele Sci Inst, I-20132 Milan, Italy
[3] Abano Terme Hosp, Abano Terme, Italy
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 8A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:176M / 176M
页数:1
相关论文
共 50 条
  • [21] Drug-eluting stents and patterns of in-stent restenosis.
    Mehran, R
    Kesanakurthy, S
    Dangas, GD
    Iyer, S
    Spatareanu, C
    Elliott, N
    Bajraktari, F
    Lander, J
    Nikitina, A
    Moussa, I
    Kreps, E
    Collins, M
    Moses, JW
    Stone, GW
    Leon, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 211E - 211E
  • [22] Paclitaxel-eluting stents for in-stent restenosis of sirolimus-eluting stents: 12 month outcomes
    Levis, Justin P.
    Lee, Steve
    Stinis, Curtis T.
    Price, Matthew J.
    Gollapudi, Raghava R.
    Valencia, Raphael
    Wong, Garrett B.
    Schatz, Richard A.
    Teirstein, Paul S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 18B - 18B
  • [23] Drug-Eluting Stents, Restenosis and RevascularizationMedikamentenbeschichtete Stents, Restenose und Revaskularisation
    Steve Ramcharitar
    Anne Louise Gaster
    Joost Daemen
    Patrick Serruys
    Herz Kardiovaskuläre Erkrankungen, 2007, 32 (4) : 287 - 295
  • [24] Drug-eluting stents in patients on chronic hemodialysis: Paclitaxel-eluting stents vs. limus-eluting stents
    Sardi, Gabriel L.
    Loh, Joshua P.
    Torguson, Rebecca
    Laynez-Carnicero, Ana
    Kitabata, Hironori
    Xue, Zhenyi
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (02) : 86 - 91
  • [25] Treatment of Femoropopliteal In-Stent Restenosis With Paclitaxel-Eluting Stents
    Zeller, Thomas
    Dake, Michael D.
    Tepe, Gunnar
    Brechtel, Klaus
    Noory, Elias
    Beschorner, Ulrich
    Kultgen, Patricia L.
    Rastan, Aljoscha
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (03) : 274 - 281
  • [26] Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients
    Dibra, A
    Kastrati, A
    Mehilli, J
    Pache, J
    Schühlen, H
    von Beckerath, N
    Ulm, K
    Wessely, R
    Dirschinger, J
    Schömig, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (07): : 663 - 670
  • [27] Sirolinnus - or paclitaxel-eluting stents to prevent coronary artery restenosis
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2209 - 2220
  • [28] Paclitaxel-Eluting Balloons or Everolimus-Eluting Stents for In-Stent Restenosis
    Alfonso, Fernando
    Jose Perez-Vizcayno, Maria
    Cuesta, Javier
    Rivero, Fernando
    Garcia-Touchard, Arturo
    Garcia del Blanco, Bruno
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (05) : 505 - 506
  • [29] Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis
    Goel, Sachin
    El-Mallah, Wael
    Ige, Mobolaji
    Gupta, Supriya
    Tuzcu, E. Murat
    Ellis, Stephen
    Kapadia, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B194 - B194
  • [30] Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis
    Cheng, Jiangtao
    Gao, Chuanyu
    Liu, Yuhao
    Wang, Zhongmin
    Zheng, Xiaohui
    Qi, Datun
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (04) : 1521 - 1524